Bioprojet Pharma - Crunchbase Company Profile & Funding

Q: Where is Bioprojet Pharma's headquarters?

Bioprojet Pharma is located in Paris, Ile-de-France, France.

Overview

Bioprojet Pharma

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Bioprojet Pharma

CB Rank

440052

Bioprojet Pharma is a Pharmaceutical Company

Founded

obfuscation

Private

Paris, Ile-de-France, France

101-250

www.bioprojet.com/en/homepage/

Biotechnology

Health Care

Key People

Olivier Finance: Chief Scientific Officer
Past Role: Sanofi, Global Head of Cardiovascular and Metabolism Business Development and Licensing
Jean-Charles Schwartz: Founder and Scientific Director

Details

Operating Status

Active

Company Type

For Profit

Founders

Jean-Charles Schwartz, Jeanne-Marie Lecomte

About the Company

The research centre Bioprojet Biotech brings together some fifty collaborators which ensure the R&D of the group. Spread in four unities, the Biotech teams are in charged to create new molecules and to realize the preclinical evaluation of these candidate’s drugs.

Phone Number

+33 (0)1 47 03 66 33

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Racecadotril (Tiorfan®/Hidrasec®)

An enkephalinase inhibitor used as an intestinal antisecretory agent to treat diarrhea by regulating water and electrolyte secretion in the digestive tract.

Pitolisant (Wakix®)

An inverse agonist/antagonist of the histamine H3 receptor used to treat excessive daytime sleepiness and cataplexy in narcolepsy patients and sleepiness in obstructive sleep apnea.